PONIARD PHARMACEUTICALS, INC.·4

Jun 11, 5:07 PM ET

SIMON NICHOLAS J III 4

4 · PONIARD PHARMACEUTICALS, INC. · Filed Jun 11, 2010

Insider Transaction Report

Form 4
Period: 2010-06-09
SIMON NICHOLAS J III
Director10% Owner
Transactions
  • Award

    Common Stock

    2010-06-09+72,28972,289 total
Holdings
  • Common Stock

    (indirect: See FN)
    6,363,249
Footnotes (2)
  • [F1]Represents shares of common stock underlying a grant of restricted stock units (the "RSUs"). The RSUs vest 50% immediately prior to each of the first two annual meetings of shareholders that occur after the 2010 annual meeting of shareholders, subject to the reporting person's continued service as a director of the issuer as of such dates.
  • [F2]The shares are held as follows: 356,660 shares held by MPM BioVentures III, L.P., ("BV III") 5,304,185 shares held by MPM BioVentures III-QP, L.P., ("BV III QP") 448,226 shares held by MPM BioVentures III GmbH & Co. Beteiligungs KG, ("BV KG") 160,225 shares held by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 93,953 shares held by MPM Asset Management Investors 2005 BVII LLC ("AM 2005"). MPM BioVentures III GP, L.P. and MPM BioVentures III LLC ("BV III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. The reporting Person is a member of BV III LLC and AM 2005. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    c02391_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION